Information between 20th August 2023 - 16th April 2024
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
Parliamentary Debates |
---|
Hormone Pregnancy Tests
94 speeches (22,165 words) Thursday 7th September 2023 - Commons Chamber Department for Business and Trade Mentions: 1: Esther McVey (CON - Tatton) Member for Bolton South East as chair of the APPG on hormone pregnancy tests. - Link to Speech 2: Jeff Smith (LAB - Manchester, Withington) She did not take any hormone pregnancy tests before giving birth to her daughter, who was born healthy - Link to Speech 3: Margaret Greenwood (LAB - Wirral West) of Medicines to recommend that hormone pregnancy tests should no longer be used. - Link to Speech 4: Andrew Gwynne (LAB - Denton and Reddish) It investigated not only Primodos and other hormone pregnancy tests, but sodium valproate and pelvic - Link to Speech 5: Yasmin Qureshi (LAB - Bolton South East) In particular, I pay tribute to the vice-chair of the APPG on hormone pregnancy tests, the hon. - Link to Speech |
Select Committee Documents |
---|
Tuesday 19th March 2024
Oral Evidence - 2024-03-19 16:15:00+00:00 Proposals for backbench debates - Backbench Business Committee Found: The first application is from Yasmin Qureshi and the all-party parliamentary group on hormone pregnancy |
Wednesday 24th January 2024
Written Evidence - Patient Safety Commissioner PSN0026 - Expert Panel: Evaluation of Government’s progress on meeting patient safety recommendations Health and Social Care Committee Found: Cumberlege and published on 8 July 2 020. 10.The IMMDS Review explored issues relating to the use of hormone |
Tuesday 5th December 2023
Correspondence - Correspondence from the Parliamentary Under Secretary of State on the Committee's Expert Panel's evaluation on Patient Safety 27.11.23 Health and Social Care Committee Found: the safety of treatments , specifically looking into cases of pelvic mesh , sodium valproate and hormone |
Friday 1st December 2023
Minutes and decisions - Session 2022-23 List of Subjects Debated Backbench Business Committee Found: Tax-free Shopping for International Visitors Westminster Hall 0.5 38 61 (23) 7 September 2023 (1) Hormone |
Thursday 26th October 2023
Formal Minutes - Session 2022-23 Formal Minutes Backbench Business Committee Found: • Sir Geoffrey Clifton- Brown: VAT reclaim on foreign shopping • Yasmin Qureshi, Hannah Bardell: Hormone |
Written Answers |
---|
Primodos
Asked by: Dan Carden (Labour - Liverpool, Walton) Tuesday 19th March 2024 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, whether she plans to take steps to implement recommendations in the report by the APPG on Hormone Pregnancy Test entitled Bitter Pill: Primodos - the forgotten thalidomide, published on 27 February 2024. Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women) We remain hugely sympathetic to the families who believe that they have suffered because of using Hormone Pregnancy Tests (HPTs). In 2017 an independent Expert Working Group (EWG) conducted a comprehensive review of the available scientific evidence and concluded that the data did not support a causal association between the use of HPTs, such as Primodos, and adverse pregnancy outcomes. This remains the Government’s position. The Government has committed to reviewing any new evidence related to HPTs and a possible causal association with adverse pregnancy outcomes. On the recently published recommendations of the HPT All-Party Parliamentary Group, we have no plans to set up an independent review to examine the findings of the EWG. In the interests of transparency, all evidence collected and papers considered by the EWG were published in 2018, along with full minutes of its discussions. Details of conflicts of interests and how these were managed were also published. The Government is reviewing Professor Danielsson’s publication to consider if it presents any new evidence or analyses not already considered by the EWG on HPTs, and will be seeking independent expert advice from the Commission on Human Medicines in due course. |
Primodos
Asked by: Jeff Smith (Labour - Manchester, Withington) Thursday 14th March 2024 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential implications for her Department’s policies of the report by the APPG on Hormone Pregnancy Test entitled Bitter Pill: Primodos - the forgotten thalidomide, published on 27 February 2024. Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women) We remain hugely sympathetic to the families who believe that they have suffered due to the use of Hormone Pregnancy Tests (HPTs). In 2017 an independent Expert Working Group conducted a comprehensive review of the available scientific evidence, and concluded that the data did not support a causal association between the use of HPTs, such as Primodos, and adverse pregnancy outcomes. This remains the Government’s position. The Government has committed to reviewing any new evidence related to HPTs, and a possible causal association with adverse pregnancy outcomes. |
Primodos
Asked by: Jeff Smith (Labour - Manchester, Withington) Thursday 14th March 2024 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, if she will implement the recommendations in the report by the APPG on Hormone Pregnancy Test entitled Bitter Pill: Primodos - the forgotten thalidomide, published on 27 February 2024. Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women) We remain hugely sympathetic to the families who believe that they have suffered due to the use of Hormone Pregnancy Tests (HPTs). In 2017 an independent Expert Working Group conducted a comprehensive review of the available scientific evidence, and concluded that the data did not support a causal association between the use of HPTs, such as Primodos, and adverse pregnancy outcomes. This remains the Government’s position. The Government has committed to reviewing any new evidence related to HPTs, and a possible causal association with adverse pregnancy outcomes. |
Primodos: Compensation
Asked by: Gavin Williamson (Conservative - South Staffordshire) Monday 25th September 2023 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, whether he plans to take steps to secure financial redress for the victims of Primodos. Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women) The Government published its response to the Independent Medicines and Medical Devices Safety (IMMDS) review in July 2021, which did not accept the recommendation to establish separate redress schemes for the three interventions covered by the review. This included a redress scheme for those harmed by Primodos. Our priority is to make medicines and devices safer, and the Government is pursuing a wide range of activity to further this aim. The 2021 response, and the Government’s December 2022 update to the response, explains the changes that have been put in place since the IMMDS Review report’s publication, and the further action the Government will take to implement the recommendations accepted and to improve patient safety. In the recent House of Commons debate of 7 September 2023 on hormone pregnancy tests, I committed to review the outstanding recommendations in relation to Primodos. |
Parliamentary Research |
---|
Debate on hormone pregnancy tests - CDP-2023-0173
Aug. 23 2023 Found: Debate on hormone pregnancy tests |
Non-Departmental Publications - Transparency |
---|
Mar. 14 2024
Medicines and Healthcare products Regulatory Agency Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023 Document: FOI 23/923 (PDF) Transparency Found: request, dated November 21st 2023 , where you asked for information about how the call for evidence on Hormone |
Scottish Select Committee Publications |
---|
Wednesday 28th February 2024
Correspondence - Letter from Minister for Public Health and Women's Health to HCSC Convener, 28 February 2024 Hughes report about redress options to Valproate and Pelvic Mesh Health, Social Care and Sport Committee Found: also stated that t hey will review any new scientific evidence which may come to light in relation to hormone |
Scottish Parliamentary Debates |
---|
Patient Safety Commissioner for Scotland Bill: Stage 3
129 speeches (143,516 words) Wednesday 27th September 2023 - Main Chamber Mentions: 1: Sweeney, Paul (Lab - Glasgow) Marie Lyon, from the Association for Children Damaged by Hormone Pregnancy Tests, told the Health, Social - Link to Speech |
Patient Safety Commissioner for Scotland Bill: Stage 3
23 speeches (63,710 words) Wednesday 27th September 2023 - Main Chamber Mentions: 1: Sweeney, Paul (Lab - Glasgow) egregiously in some cases, including in the cases of women who were impacted by transvaginal mesh and hormone - Link to Speech |